Kevin Gannon, CEO, Robert A. Stanger & Co. “There’s a big pull to alternative investments right now because of volatility of the stock market,” Kevin Gannon, CEO of Robert A. Stanger & Co., said. Add Edward Jones, the closely held private partnership with more than 20,000 financial advisors and $2.2 trillion in client assets, to...

Understand every aspect of the global economy – and know how to make your next move. 

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster cancer treatment, the company said. Merck said last week its biggest tariff exposure is through Keytruda...